Modulation of the clonal burden in patients with lower-risk myelodysplastic neoplasms treated with imetelstat

Geron Corporation published this content on January 12, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on February 03, 2026 at 15:56 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]